Food Allergy

An analysis of global online conversations among health care professionals on social media in February showed an overarching sense of enthusiasm about FDA approval of the first cellular therapy to treat unresectable or metastatic melanoma.

Robert Wood, MD, FAAAAI, professor of pediatrics Johns Hopkins University School of Medicine, recounted the results of the OUtMATCH study.

Patients with food allergy who used omalizumab experienced increased thresholds for reacting to peanut and other foods to which they were allergic, according to a study published in The New England Journal of Medicine.

WASHINGTON — A nurse-led intervention improved pediatric food allergy knowledge, although it also revealed “concerning” shortcomings in certain areas of identification and management, research showed.

WASHINGTON — Children from lower-income homes had more allergic reactions to food than children from higher-income households, according to a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

The FDA approved omalizumab so people with immunoglobulin E-mediated food allergies can build tolerance to allergens, but experts warned that the biologic is not a cure.

Healio has compiled February’s most-read news in asthma and allergy.

WASHINGTON — Omalizumab increased thresholds for reacting to peanut and other common allergenic foods during accidental exposure, according to a study presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

The gut microbiome has gained attention for its critical role in health and disease in recent years. Among its various influences, the microbiome’s impact on the development and severity of food allergies is particularly important.

Anaphylaxis and food allergies appeared associated with psychiatric disorders, according to a study included in the program of the American Academy of Allergy, Asthma & Immunology Annual Meeting.